|
|
|
|
|
| Using open source clinical trial software in regulatory environments will be the topic of a panel discussion at the upcoming DIA annual meeting on June 24th in Boston |
|
|
| Scientists at The Feinstein Institute for Medical Research have used the hunger hormone Ghrelin to block organ injury after intestinal ischemia-reperfusion, a common surgical problem with a high risk of death. |
|
|
| Doctor Simon Ourian, a leading authority in the use of BOTOX® in the U.S. rejects the recent BOTOX® study. 7 reasons why BOTOX® is safe. |
|
|
| Amphora Research Systems ( http://www.amphora-research.com ), a key provider of Patent Evidence Systems, is launching its new Custodian's Console to give those responsible for the integrity and performance of the Patent Evidence process more visibility and control. With clear graphical displays highlighting research throughput and signature compliance plus a one-click option to verify the integrity of the document repository, the console puts control in the hands of the Custodian. |
|
|
| Connectionsforwomen.com is showcasing BioEDEN, a remarkable bio-science company which is the first in the world to collect, assess and cryogenically store living tooth cells which then hold the potential to save a life by way of treatment for a life-threatening disease or debilitating condition that may occur in the lifetime of the donor or may be used also to treat a blood relative. |
|
|
| Finalists have been announced for the 2008 Life Science Industry Awards, which recognize those life science suppliers that are best-in-class in both product categories and customer communications and support categories. The 45 finalists represent the five companies receiving the highest overall scores in each of 20 award categories. The finalists were selected from the more than 500 companies nominated. |
|
|
| Today Percepta Associates Inc. announced the release of Series Two of its Gene Expression Profiling Life Science DashboardTM market research report. Drawing comparisons to the findings of Series One published in February 2007, Percepta reports measurable shifts in market share within this market. |
|
|
| Histogen, Inc., a regenerative medicine company developing solutions based on the products of newborn fibroblasts, today announced the initial close of Series A financing at $5.35 million. |
|
|
| New discoveries in pharmaceutical, medical, and genetic research could produce a medication that keeps users thin no matter what their diet or physical routine, according to research by the global consulting firm Social Technologies. |
|
|
| Nanopoint, Inc. has announced its strong network of Asian distributors who include DayMoon Industries of Korea;, DI Biotech LTD of Korea; JC Biotech of Korea; JK Bio of Delhi, India; Joagene BioScience of Korea, Quantum Design China of China; Quantum Design Japan of Japan; and Trade 21 Pte., LTD of Singapore and SinWan Biotech LTD of Taiwan. |
|
|
